Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Medical Solutions Group Plc LSE:AMS London Ordinary Share GB0004536594 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.50 -1.32% 262.00 260.50 262.50 267.50 261.50 267.50 215,585 16:35:16
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 86.8 10.1 4.0 65.7 564

Advanced Medical Solutions Share Discussion Threads

Showing 7351 to 7375 of 7375 messages
Chat Pages: 295  294  293  292  291  290  289  288  287  286  285  284  Older
DateSubjectAuthorDiscuss
08/4/2021
17:59
Aiui Rapid Liquiband was expected to get FDA approval in Q1 this year, and that should help, plus of course the very successful vaccination programme in the US which should soon increase elective surgery to normal levels. AMS could prove a tasty morsel for one of the many giant US medical companies.
dozey3
08/4/2021
13:26
Since April 5th this is a different company - according to the sp! ;-)
wetdream
07/4/2021
14:18
AMS are a rock solid Company with a good management team. They are waiting approval from FDA on some next generation products which IMHO will take the share price to a higher level.
dealit
07/4/2021
10:39
Off the radar
nickg2
30/3/2021
16:47
As elective surgery starts to get busier as we come out of lockdown who thinks this company will start its climb back up?
nickg2
11/3/2021
11:08
Amazing some of the six-figure trades that suddenly appear in a largely ignored stock. Presumably just blocks being transferred at an agreed price, as the share price barely moves.
wetdream
11/3/2021
09:51
If the trading statement is correct steady progress in difficult times.
dealit
11/3/2021
07:55
Plenty of volume yesterday. Everything’s looking rosy.
wetdream
22/2/2021
15:26
Well, it was to someone. ;-)
wetdream
22/2/2021
12:30
500k could have been a buy
cynic1
22/2/2021
10:40
Always seems to be someone with 500k to sell... ;-)
wetdream
21/2/2021
22:47
Hi All, an article on the investment case for AMS post half year 2020 results. Available here: hxxps://www.thetwentiestrader.com/post/advanced-medical-solutions-licking-its-wounds
thetwentiestrader
21/2/2021
16:43
AMS were first tipped in the MoS in 2002. Just wish I'd bought more at 10p. Solid company with good forward thinking management.
cynic1
21/2/2021
15:35
Mail on Sunday
cynic1
21/2/2021
14:37
Good, but what is the MOS?
dozey3
21/2/2021
13:40
AMS one of the top 10 biggest bargain tips in the MOS
cynic1
09/12/2020
21:53
dealit, I have a love/hate relationship with AMS... I’ve always thought of them as a well-run, if undynamic, company with a solid product range and in a pretty ‘fireproofR17; business sector. A bit too dependent on acquisitions (that I struggle to appreciate) but hey-ho, ‘steady as she goes’. But then along came Trump with his ‘America First’ campaign in the middle of the pandemic and AMS just got left behind. Not entirely their fault, but irritating that it’ s set them back as you point out at least 12 months. They’ve done well to hold on to some quality funds as supporters, so I guess extra patience is required.
wetdream
09/12/2020
15:42
wetdream-I have posted part of an announcement from earlier in the year and feel that AMS S/P should head north on FDI approval IMHO.---- The LiquiBand® XL critical pilot study has been completed with three different formulations successfully meeting our objective of 14-day wear time. However, some of the variants demonstrated extended set time. The lead formulation, which we believe maximises our potential for long term commercial success on all product features, is an accelerated formulation of LiquiBand® that will require additional stability and biocompatibility data along with a repeat of the clinical study as part of the FDA filing. The additional work required on this lead formulation means that we now expect to file for 510K approval in the first quarter of 2021. We expect the financial impact of this delayed approval to be offset by the stronger than anticipated LiquiBand® market share improvement and short term commercial agreements with US hospitals to encourage additional LiquiBand® adoption in the run up to the LiquiBand® XL approval. Once approved, LiquiBand® XL will allow entry into the market for care of larger wounds and unlock further growth potential in the LiquiBand® business with all partners.
dealit
07/12/2020
09:16
Good for divis - hence continued institutional support. Doubt anyone holds for capital growth. Been on the slide for the last couple of years.
wetdream
02/12/2020
18:33
I've held quite a few here for years, adding the divi's back as shares I see this doing well in the next few years again- happy to hold thru the doldrums unloved but a great long-term hold for me
malcontent
02/12/2020
18:26
Not a high profile sector, I guess. Always thought of them as a takeover target, but not in these Covid-obsessed times.
wetdream
01/12/2020
22:15
Really nice jump Not even sure if anyone cares anymore.
whitebicycle
24/11/2020
07:52
Looks like the news caused some trading algorithms to go into meltdown! Dozens of single share trades before 8.30am. Weird.
wetdream
23/11/2020
16:32
The market loved todays acquisition news by AMS.
dealit
23/11/2020
16:31
Advanced Medical Solutions acquires Raleigh Adhesive Coatings, reports Investor's Champion. For the 6 months ending 31 October Raleigh generated revenue of £3.9m and operating profit of £0.8m, compared to the prior year’s loss of £0.3m. The £22m acquisition cost therefore represents quite a multiple, suggesting AMS thinks highly of this business.
energeticbacker
Chat Pages: 295  294  293  292  291  290  289  288  287  286  285  284  Older
ADVFN Advertorial
Your Recent History
LSE
AMS
Advanced M..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210417 18:45:08